Invention Application
US20160287569A1 COMBINATION THERAPY INCLUDING AN MDM2 INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS
审中-公开
联合治疗包括MDM2抑制剂和一种或多种其他药物治疗癌症的药物活性剂
- Patent Title: COMBINATION THERAPY INCLUDING AN MDM2 INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS
- Patent Title (中): 联合治疗包括MDM2抑制剂和一种或多种其他药物治疗癌症的药物活性剂
-
Application No.: US15035438Application Date: 2014-11-11
-
Publication No.: US20160287569A1Publication Date: 2016-10-06
- Inventor: Sean CAENEPEEL , Jude CANON , Paul HUGHES , Jonathan D. OLINER , Anne Y. SAIKI , Richard J. RICKLES
- Applicant: AMGEN INC.
- Applicant Address: US CA Thousand Oaks
- Assignee: AMGEN INC.
- Current Assignee: AMGEN INC.
- Current Assignee Address: US CA Thousand Oaks
- International Application: PCT/US2014/065034 WO 20141111
- Main IPC: A61K31/451
- IPC: A61K31/451 ; A61K31/437 ; A61K31/519 ; A61K31/5025 ; A61K31/496 ; A61K31/365 ; A61K31/166 ; A61K31/635 ; A61K31/4045 ; A61K31/706 ; A61K31/7068 ; A61K31/704 ; A61K31/506 ; A61K31/44
Abstract:
The present invention provides combination therapy that includes an MDM2 inhibitor and one or more additional pharmaceutically active agents, particularly for the treatment of cancers. The invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers.
Information query
IPC分类:
